Cardlytics, Inc. under Securities Fraud Investigation: Schall Law Firm Encourages Affected Shareholders to Take Action

The Schall Law Firm Investigates Cardlytics, Inc. for Potential Securities Law Violations Los Angeles, CA – The Schall Law Firm, a leading national shareholder rights litigation firm, announces that it is investigating potential securities laws violations by Cardlytics, Inc. (“Cardlytics” or “the Company”) (NASDAQ: CDLX). This investigation follows a lawsuit filed on behalf of investors…

Read More

Adam Ferrari Announces Annie O’Brien as 2024 Recipient of the Adam Ferrari Health Science Scholarship: Empowering the Next Generation of Healthcare Professionals

Adam Ferrari Announces Annie O’Brien as the 2024 Health Science Scholarship Recipient Adam Ferrari, the successful entrepreneur and founder of the Ferrari Energy LLC, recently made an exciting announcement. He proudly announced Annie O’Brien as the recipient of the Adam Ferrari Health Science Scholarship for the year 2024. Annie is currently pursuing her nursing degree…

Read More

The Schall Law Firm Encourages Investors Suffering Losses from Revance Therapeutics, Inc. to Join Securities Fraud Class Action

Class Action Lawsuit Filed Against Revance Therapeutics, Inc.: On January 22, 2025, The Schall Law Firm announced that it had filed a class action lawsuit against Revance Therapeutics, Inc. (“Revance” or “the Company”) (NASDAQ:RVNC) in the United States District Court for the Central District of California. The lawsuit alleges that the Company violated the Securities…

Read More

Pomerantz Law Firm Investigates Potential Securities Claims Against Sezzle, Inc. (SEZL): What Does This Mean for Investors?

Pomerantz LLP Investigates Claims Against Sezzle Inc.: What Does It Mean for You and the World? In the bustling city of New York, the law firm Pomerantz LLP has recently announced that they are investigating potential securities fraud claims on behalf of investors in Sezzle Inc. (Sezzle or the Company). Sezzle is a popular buy…

Read More

The Schall Law Firm Encourages Rentokil Initial Plc Shareholders Suffering Losses to Consider Joining Securities Fraud Class Action

Class Action Lawsuit Filed Against Rentokil Initial plc: What Does It Mean for Investors and the World On January 22, 2025, The Schall Law Firm announced that it had filed a class action lawsuit against Rentokil Initial plc (“Rentokil” or “the Company”) (NYSE:RTO) for alleged violations of the Securities Exchange Act of 1934. The lawsuit,…

Read More

Investigation Alert: Pomerantz Law Firm Represents Intellia Therapeutics (NTLA) Investors over Potential Securities Claims

Pomerantz LLP Investigates Intellia Therapeutics, Inc. on Behalf of Investors New York, NY – January 22, 2025 – Pomerantz LLP, a leading securities law firm, is investigating potential claims on behalf of investors of Intellia Therapeutics, Inc. (“Intellia” or the “Company”) (NASDAQ:NTLA). Background Intellia Therapeutics is a leading genome editing company developing potential therapeutic and…

Read More